TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04963816

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound guided quadratus lumborum block
Description: Ultrasound guided quadratus lumborum block will be done to all groups using curved array transducer 5_2 MHz with the patient in supine position and the block will be done by anterior approach

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound guided quadratus lumborum block
Description: Ultrasound guided quadratus lumborum block will be done to all groups using curved array transducer 5_2 MHz with the patient in supine position and the block will be done by anterior approach

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: ultrasound guided quadratus lumborum block
Description: Ultrasound guided quadratus lumborum block will be done to all groups using curved array transducer 5_2 MHz with the patient in supine position and the block will be done by anterior approach

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone Phosphate 4 MG/ML Injectable Solution intravenously
Description: Using dexamethasone as an adjuvant to bupivacaine in ultrasound guided quadratus lumborum block which will be given intravenously in group A

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Injection
Description: Bupivacaine will be given to all groups locally with QLB

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Injection
Description: Bupivacaine will be given to all groups locally with QLB

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Bupivacaine Injection
Description: Bupivacaine will be given to all groups locally with QLB

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone Phosphate 4 MG/ML Injectable Solution locally
Description: Using dexamethasone as an adjuvant to bupivacaine in ultrasound guided quadratus lumborum block which will be given locally in Group B
Study: NCT04782349

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mulligan mobilization with low level laser therapy and traditional physical therapy exercises
Description: for mulligan mobilization: for improving the limited range of motion of shoulder joint, the therapist will apply posterolateral mobilization for the shoulder joint. Three sets of painless glides of 10 repetitions will be applied with a rest interval of 30 s between each set.~For low level laser application: Laser specifications is as follows: 850 nm wave length and pulsed application with 8 W applied for 20 minutes. laser will be applied over painful points of the shoulder.~For traditional physical therapy exercises: the patients will receive the following exercise program: self stretching exercises for shoulder joint, pully exercises, back climbing exercises, finger ladder exercises, circumduction exercises and pendulum exercises

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low level laser therapy and traditional physical therapy exercises
Description: patients in this group will receive low level laser and traditional physical exercises as described before for group (A)
Study: NCT06008431

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) (active)
Description: The tDCS montage is developed to modulate the functional connectivity between the dorsal attention network and the default network.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS) (Sham)
Description: The tDCS Acti- Sham montage is developed to recreate the cutaneous sensations associated with tDCS, yet essentially a null electrical field over the networks of interest.
Study: NCT04224792

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Center-based exercise program
Description: A routine individualized exercise prescription and supervised exercise sessions at a minimum of once per week for 11 weeks with an exercise prescription updated monthly.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Description: A one-time supervised exercise session with Cardiac Rehabilitation staff and a routine individualized exercise prescription for exercises to do at home. Additionally, weekly telephone followup calls by a clinical exercise physiologist for 11 weeks consisting of an exercise tip.
Study: NCT04457128

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Just-in-Time Adaptive Intervention
Description: Randomized factorial design

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Just-in-Time Adaptive Intervention
Description: Randomized factorial design

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Just-in-Time Adaptive Intervention
Description: Randomized factorial design
Study: NCT05710965

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FRx-001
Description: Wearable digital therapy

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FRx-003
Description: Wearable digital therapy

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FRx-004
Description: Wearable digital therapy
Study: NCT06190743

Intervention type: OTHER
Intervention: Prevention events organized by participating centers
Description: Cardiovascular disease primary prevention events organized by centers participating in the study where capillary sampling will be performed on subjects to quantify plasma levels of cardiovascular risk factors and validated questionnaires will be administered
Study: NCT04904003

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation Intervention
Description: Strength, flexibility, endurance, balance, mobility, (self-efficacy)
Study: NCT04782349

Intervention type: OTHER
Group type: OTHER
Intervention: physical therapy exercises
Description: The patients will receive traditional physical therapy exercises only as described before for group (A)
Study: NCT06056180

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Balance Training
Description: Participants will be given static and dynamic balance training with a balance platform game console (20 minutes) containing interactive video games based virtual reality for a total of 6 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance Training
Description: Participants will be given static and dynamic balance training with a balance platform game console (20 minutes) containing interactive video games based virtual reality for a total of 6 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor İmagery Training
Description: For motor imagery training, two visualization scenarios will be created: anterior and posterior motor imagery. One of the visualization scenarios appropriate to each individual's needs will be used. Participants will be asked to perform kinesthetic or visual motor imagery in accordance with the scenario they listened to (10 minutes).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Action Observation Training
Description: Action observation training will be done using video modeling method. The video content will include Nintendo Wii games in which the games that the person will play in that session are played by someone else and successful scores are achieved (10 minutes).
Study: NCT05500651

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dance and Movement Therapy (DMT)
Description: Dance and movement therapy is planned to be applied once a week as a total of 12 sessions of 60 minutes. First session; meeting, warming up, determining the group rules, explaining the principles, determining the expectations activities. Subsequent sessions; The greeting is completed with warm-up, initiation, continuation and closing activities. During the warm-up phase, the whole group comes together to form a circle, generally standing, in order to ensure the group dynamic. It starts with simple warm-up exercises such as breathing and muscle relaxation and continues with body awareness exercises. In the continuation (development of themes) stage, practices are included according to the characteristics and needs of the group.
Study: NCT04904003

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation Intervention
Description: Strength, flexibility, endurance, balance, mobility, (self-efficacy)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation Intervention
Description: Strength, flexibility, endurance, balance, mobility, (self-efficacy)
Study: NCT05089149

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Clinical examination centered on congestion
Description: Clinical examination (including the EVEREST, ASCEND and Ambrosy scores) centered on congestion will be performed during day hospitalization or consultation

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cardiac, pulmonary, peritoneal, jugular, renal Doppler ultrasounds and liver elastography
Description: Cardiac, pulmonary, peritoneal, jugular and renal Doppler ultrasounds will be performed during day hospitalization or consultation/ peritoneal, jugular and renal Doppler ultrasounds and liver elastography are optional
Study: NCT04828135

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperpolarized 129Xenon gas
Description: Each xenon dose will be limited to a volume less than 25% of subject lung capacity (TLC),
Study: NCT05264168

Intervention type: DRUG
Intervention: Rivaroxaban
Description: Any rivaroxaban dispensing claim is used as the reference group
Study: NCT05518006

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: PreMama Balance
Description: Premama Balance is a blend of the following: Vitex (Chasteberry Extract), commonly used to help regulate hormones; Antioxidants, Selenium, and Magnesium, also help support the cleansing of hormonal birth control from the liver and help strengthen the uterine lining.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Drink
Description: Blended Placebo drink
Study: NCT05309044

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Planetary Health Diet Group
Description: This group includes a diet proportional to the EAT-Lancet reference diet (2500 kcal), with a caloric intake of 1200 to 1800 kcal, in addition to a behavioral change protocol during the time of the study (4 months).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low-fat diet group
Description: This group includes a low-fat, low-calorie diet (1200-1800 kcal), in addition to a behavioral change protocol

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Waiting list group
Description: This group will only receive digital information with recommendations on healthy eating. When the study has finished, this group will receive a behavioral change protocol with a low-fat, low-calorie diet.
Study: NCT06393803

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2mg KH607 tablets
Description: Subject receive KH607 tablets or placebo orally single dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5mg KH607 tablets
Description: Subject receive KH607 tablets or placebo orally single dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10mg KH607 tablets
Description: Subject receive KH607 tablets or placebo orally single dose or multiple doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10mg KH607 tablets
Description: Subject receive KH607 tablets or placebo orally single dose or multiple doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20mg KH607 tablets
Description: Subject receive KH607 tablets or placebo orally single dose or multiple doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20mg KH607 tablets
Description: Subject receive KH607 tablets or placebo orally single dose or multiple doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 30mg KH607 tablets
Description: Subject receive KH607 tablets or placebo orally single dose or multiple doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 30mg KH607 tablets
Description: Subject receive KH607 tablets or placebo orally single dose or multiple doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 40mg KH607 tablets
Description: Subject receive KH607 tablets or placebo orally single dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 50mg KH607 tablets
Description: Subject receive KH607 tablets or placebo orally single dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 60mg KH607 tablets
Description: Subject receive KH607 tablets or placebo orally single dose.
Study: NCT05264168

Intervention type: DRUG
Intervention: Apixaban
Description: Any apixaban dispensing claim is used as the exposure group
Study: NCT05986266

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carbetocin
Description: To compare efficacy of intravenous carbetocin to intramyometrial injection of adrenaline in decreasing intraoperative blood loss and need for blood transfusion during abdominal myomectomy.
Study: NCT06247046

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Live SK08 powder
Description: Oral Powder

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral Powder
Study: NCT05089149

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood sample retrieved for biological assessment and biobanking
Description: Blood sample retrieved for biological assessment and biobanking will be performed during day hospitalization or consultation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telephone follow-up
Description: Telephone follow-up will be performed 3, 12 and 24 months after visit (during day hospitalization or consultation)
Study: NCT04805216

Intervention type: PROCEDURE
Intervention: Blood test
Description: Participants will have blood tests at baseline (nearest 30 day incremental time point after 2nd dose of Covid-19 vaccine, +/- 7 days):~* T, B \& NK cells~* Full Blood Count and differential~* Serum Immunoglobulins~* Antibodies against VZV, CMV, Rubella~* Quantiferon assay (T-Cell response)~* Covid antibody assay (LIAISON® SARS-CoV-2 S1/S2 IgG quantitative assay)~Participants will have blood tests during follow up (after second dose of Covid-19 vaccine) with a window of +/- 7 days:~* Blood test 2 - performed at the next 30 day time point (Covid antibody assay)~* Blood test 3 - performed at the next 30 day time point (Covid antibody assay and quantiferon\* if final blood test)~* Blood test 4 (optional) - performed at the next 30 day time point (Covid antibody assay)~* Blood test 5 (optional) - performed at the next 30 day time point (Covid antibody assay and quantiferon\* if final blood test)~  * Quantiferon assay will be only be performed where possible.

Intervention type: PROCEDURE
Intervention: Blood test
Description: Participants will have blood tests at baseline (nearest 30 day incremental time point after 2nd dose of Covid-19 vaccine, +/- 7 days):~* T, B \& NK cells~* Full Blood Count and differential~* Serum Immunoglobulins~* Antibodies against VZV, CMV, Rubella~* Quantiferon assay (T-Cell response)~* Covid antibody assay (LIAISON® SARS-CoV-2 S1/S2 IgG quantitative assay)~Participants will have blood tests during follow up (after second dose of Covid-19 vaccine) with a window of +/- 7 days:~* Blood test 2 - performed at the next 30 day time point (Covid antibody assay)~* Blood test 3 - performed at the next 30 day time point (Covid antibody assay and quantiferon\* if final blood test)~* Blood test 4 (optional) - performed at the next 30 day time point (Covid antibody assay)~* Blood test 5 (optional) - performed at the next 30 day time point (Covid antibody assay and quantiferon\* if final blood test)~  * Quantiferon assay will be only be performed where possible.
Study: NCT05089149

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Kansas City Cardiomyopathy Questionnaire (KCCQ)
Description: Questionnaire centered on patient's quality of life at discharge and 3, 12 and 24 months after discharge
Study: NCT05099549

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AFM24
Description: Tetravalent, bispecific EGFR- and CD16A-binding innate cell engager.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AFM24
Description: Tetravalent, bispecific EGFR- and CD16A-binding innate cell engager.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AFM24
Description: Tetravalent, bispecific EGFR- and CD16A-binding innate cell engager.
Study: NCT05986266

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbetocin
Description: To compare efficacy of intravenous carbetocin to intramyometrial injection of adrenaline in decreasing intraoperative blood loss and need for blood transfusion during abdominal myomectomy.
Study: NCT05717504

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality of life survey
Description: A quality of life survey will be performed at the end of the follow-up period. The survey will be done over the phone or in person if the follow-up visit is in person.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality of life survey
Description: A quality of life survey will be performed at the end of the follow-up period. The survey will be done over the phone or in person if the follow-up visit is in person.
Study: NCT06264245

Intervention type: OTHER
Intervention: Audiological profile
Description: Video otoscopy Tympanometry High-frequency tonal audiometry

Intervention type: OTHER
Intervention: Audiological profile
Description: Video otoscopy Tympanometry High-frequency tonal audiometry

Intervention type: OTHER
Intervention: Hearing self-assessments
Description: Hearing skills questionnaire Subjective assessment of tinnitus using a visual analogue scale Self-questionnaire on the impact of tinnitus Hyperacusis self-questionnaire

Intervention type: OTHER
Intervention: Hearing self-assessments
Description: Hearing skills questionnaire Subjective assessment of tinnitus using a visual analogue scale Self-questionnaire on the impact of tinnitus Hyperacusis self-questionnaire

Intervention type: OTHER
Intervention: Objective and subjective audiological tests
Description: Acoustic Omission Measurement of the stapedial reflex by tympanometry High-frequency tonal audiometry - exposed ear only Speech audiometry in noise Tinnitus and subjective discomfort thresholds Psychoacoustic intensity perception test

Intervention type: OTHER
Intervention: Objective and subjective audiological tests
Description: Acoustic Omission Measurement of the stapedial reflex by tympanometry High-frequency tonal audiometry - exposed ear only Speech audiometry in noise Tinnitus and subjective discomfort thresholds Psychoacoustic intensity perception test

Intervention type: OTHER
Intervention: Self-assessment of exposure sound quality
Description: A self-assessment of the sound quality of the manipulated sounds heard during the exhibition will be carried out during the second follow-up visit. The elements on which the participant will be asked to make a qualitative judgement will relate to intelligibility difficulties or not; background noise (these two items in the form of a mark between 0 and 10); the clear, muffled or shrill nature of the sounds, their resonant or saturated side.

Intervention type: OTHER
Intervention: Self-assessment of exposure sound quality
Description: A self-assessment of the sound quality of the manipulated sounds heard during the exhibition will be carried out during the second follow-up visit. The elements on which the participant will be asked to make a qualitative judgement will relate to intelligibility difficulties or not; background noise (these two items in the form of a mark between 0 and 10); the clear, muffled or shrill nature of the sounds, their resonant or saturated side.
Study: NCT06352489

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Posterior component separation technique.
Description: By dividing the posterior rectus sheath, a posterior plane is reached which can be advanced by dividing the transversus abdominis muscle with reinforcement of the midline with synthetic mesh.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Posterior component separation technique.
Description: By dividing the posterior rectus sheath, a posterior plane is reached which can be advanced by dividing the transversus abdominis muscle with reinforcement of the midline with synthetic mesh.
Study: NCT05334264

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cervical cerclage
Description: McDonald cervical cerclage will be applied using Mersaline braided tape with double needle. Single stitch (4 bites) will be applied as close as possible to the level of internal os. The Knot will be put either anterior or posterior according to the surgeon desire.
Study: NCT05222503

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Knee Brace + OPUM Digital Knee
Description: Knee Brace + OPUM Digital Knee

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Knee Brace
Description: Knee Brace without OPUM Digital Knee
Study: NCT05891691

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Activities, Yoga, Massage
Description: The program begins with music and dance movements using percussion instruments (rhythm stick, stone triangle, drum, cymbal, tambourine, maracas, etc.) and body percussion. In this phase, the children will follow the instructions of the researcher. The goal is to warm up the bodies and musically experience the beginning of the program After the warm-up, yoga postures are combined with breathing techniques that focus on developing awareness of body sensations and feelings.The daily program ends with massage. During the massage application, the children sit in a circle. The massage is performed by the children observing the movements of the researcher on their arms and legs and applying them on their own arms and legs.Yoga postures, breathing techniques, and massage practices are accompanied by stories to ensure children's active participation, encourage their development, and facilitate their acquisition of new approaches.
Study: NCT05514106

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: meta-iodobenzylguanidine (MIBG) (123I)
Description: 1 administration of 123I-MIBG for a single SPECT scan

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 123I-MIBG scintigraphy
Description: SPECT scan involving 123I-MIBG as the ligand